Market Overview

Poniard Pharma Beats EPS By $0.02 (PARD)

Share:

Poniard Pharma Reports ($0.11) Vs. ($0.13) Estimate (NASDAQ: PARD).

Posted-In: Earnings News

 

Related Articles (PARD)

Get Benzinga's Newsletters